Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis

Trial Profile

Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Risedronic acid (Primary) ; Teriparatide (Primary)
  • Indications Male osteoporosis
  • Focus Therapeutic Use
  • Acronyms RPM Study
  • Most Recent Events

    • 16 Oct 2012 Results presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
    • 13 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top